December 2010 and December 2012 dates for adopting GLN and GTIN codes mark steady, if slow, progress
A couple years ago, hospital group purchasing organizations (GPOs) adopted a voluntary goal of applying GS1 standards to their contracts and ordering processes during 2010 and 2012, calling it the “sunrise” program (as in, “A new day is dawning…”). The sunrise goals were widespread adoption of GLN (Global Location Number) for identifying specific facilities (i.e., warehouses or pharmacies) by Dec 31, 2010, and GTIN (Global Trade Item Number) for identifying specific products by Dec. 31, 2012. An annual survey conducted by the Univ. of Arkansas Center for Innovation in Healthcare Logistics (CIHL; Fayetteville, AR) finds that awareness of the sunrise standards is high (82%); that planning to implement data standards is slightly higher in 2011 than in 2010 (71% vs. 68%), and that GPOs are farthest along in actually doing the GLN implementations (66% use GLN in some or all appropriate transactions, as compared to 38% of manufacturers, and 22% of providers).
The upcoming GTIN date is expected to be met by 63% of GPOs, 43% of manufacturers, and 25% of providers—but across the board of all respondents only 31% are committed to that goal. Year-over-year comparisons of these commitments are somewhat difficult to discern because the survey base has dropped by nearly two-thirds. However, according to one of the researchers, Edward Pohl, PhD, the likelihood is that the bigger manufacturers, GPOs and providers are better staffed and capitalized to take on the conversion, so that a higher percentage of overall healthcare supply chain transactions will be conducted using the GS1 standards.
Originally, the leading GPOs stated that they would not accept transactions from suppliers (i.e., manufacturers) not using the GLN and, soon, GTIN definitions, but that is obviously a goal, rather than a requirement. GLNs and GTINs are designed to make transactions more automation-friendly; when exact locations and exact product identifiers can be agreed on, less reconciliation of transaction details need to be reconciled. GLN and especially GTIN are also a preamble, of sorts, to item-level serialization of pharmaceutical products; the GTIN can actually be incorporated into the unique identifier of an item.
The survey is sponsored by the Healthcare Industry Supply Chain Institute (www.hisci-net.org) and the Healthcare Supply Chain Assn. (www.supplychainassociation.org); HSCA, by the way, is the new identity of HIGPA, the Healthcare Industry Group Purchasing Assn.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.